3 October 2022
| Rosalyn Painter, Clare Abbott
|
EYE - General
Rosalyn Painter spoke to Clare Abbott, a member of the Eye Clinic Liaison Officer (ECLO) team at Oxford Eye Hospital, about her day-to-day job as an ECLO, how the role can help patients, and the ongoing importance of their work....
Supercomputer: “The answer to the great question of Life, the Universe and Everything is…”Programmer: “Yes…?”Supercomputer: “42. It was a tough assignment”.Programmer: “42? Is that all you have got to show for seven and a half million years work?” In this...
There’s no denying that now, more than ever, we are better connected to our electronic devices; 24/7, around the clock. The phenomenon of ‘Zoom’ and ‘Microsoft Teams’ is shaping the future of medical education, national trainee recruitment and conference access....
As society places increasing emphasis on mental health and access to technology increases, the structure and prioritisation within low vision appointments is evolving. These changes bring new challenges and demands in terms of our clinical support, requiring us to consider...
Perhaps one of the less well-known benefits of being a member of the Royal College of Ophthalmologists (RCOphth) is access to the range of scholarships, awards and prizes that we offer. Many of you will be aware of the annual...
They were all SEEN by one individual who then took their story to the world to witness. He saw them through his eyes and captured them in his camera lens. Through his vision and through their visual interpretations, an extraordinary,...
Diabetes – a historical perspective Diabetes mellitus (DM) is a chronic disease caused by inherited and / or acquired deficiency in production of insulin by the pancreas, or by the ineffectiveness of the insulin produced. Such a deficiency results in...
Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...
A machine might be called intelligent if its response to questions could convince a person that it was human, a test proposed by Alan Turing in 1950 [1]. The author considers potential applications of artificial intelligence (AI) using machine learning...
The business world tells us, “Know your why.” But increasingly, we live in a society where people think, “Why bother?” In this interview, David wants to know what makes Carrie MacEwen tick, and why she bothered to get involved locally,...